Skip to Main Content

Author Details

Barry S Taylor
Memorial Sloan Kettering Cancer Center
2006
154
77
Nathan Sheffield (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
37561983Associations Between Cancer Predisposition Mutations and Clonal Hematopoiesis in Patients With Solid Tumors.JCO Precis Oncol2023
37561983Associations Between Cancer Predisposition Mutations and Clonal Hematopoiesis in Patients With Solid Tumors.JCO Precis Oncol2023
35304457The evolution of RET inhibitor resistance in RET-driven lung and thyroid cancers.Nat Commun2022
35383193Author Correction: The evolution of RET inhibitor resistance in RET-driven lung and thyroid cancers.Nat Commun2022
35440569AKT mutant allele-specific activation dictates pharmacologic sensitivities.Nat Commun2022
35425699Tumor Suppressor Par-4 Regulates Complement Factor C3 and Obesity.Front Oncol2022
35613620ARAF protein kinase activates RAS by antagonizing its binding to RASGAP NF1.Mol Cell2022
35477182Germline Pathogenic Variants Impact Clinicopathology of Advanced Lung Cancer.Cancer Epidemiol Biomarkers Prev2022
35355015Anatomic position determines oncogenic specificity in melanoma.Nature2022
35304457The evolution of RET inhibitor resistance in RET-driven lung and thyroid cancers.Nat Commun2022
35383193Author Correction: The evolution of RET inhibitor resistance in RET-driven lung and thyroid cancers.Nat Commun2022
35477182Germline Pathogenic Variants Impact Clinicopathology of Advanced Lung Cancer.Cancer Epidemiol Biomarkers Prev2022
35613620ARAF protein kinase activates RAS by antagonizing its binding to RASGAP NF1.Mol Cell2022
35440569AKT mutant allele-specific activation dictates pharmacologic sensitivities.Nat Commun2022
35425699Tumor Suppressor Par-4 Regulates Complement Factor C3 and Obesity.Front Oncol2022
35355015Anatomic position determines oncogenic specificity in melanoma.Nature2022
33004339TRK xDFG Mutations Trigger a Sensitivity Switch from Type I to II Kinase Inhibitors.Cancer Discov2021
34103301Recurrent Mutations in Cyclin D3 Confer Clinical Resistance to FLT3 Inhibitors in Acute Myeloid Leukemia.Clin Cancer Res2021
33833465Respiratory complex and tissue lineage drive recurrent mutations in tumour mtDNA.Nat Metab2021
34090768Erratum to 'Germline-focussed analysis of tumour-only sequencing: recommendations from the ESMO Precision Medicine Working Group': [Annals of Oncology 30 (2019) 1221-1231].Ann Oncol2021
34250397Utility of Serial cfDNA NGS for Prospective Genomic Analysis of Patients on a Phase I Basket Study.JCO Precis Oncol2021
34250384Prevalence and Characterization of Biallelic and Monoallelic <i>NTHL1</i> and <i>MSH3</i> Variant Carriers From a Pan-Cancer Patient Population.JCO Precis Oncol2021
34135330Homing in on genomic instability as a therapeutic target in cancer.Nat Commun2021
33199492Targeting Germline- and Tumor-Associated Nucleotide Excision Repair Defects in Cancer.Clin Cancer Res2021
33303690AKT1 E17K Inhibits Cancer Cell Migration by Abrogating β-Catenin Signaling.Mol Cancer Res2021
33229459Combined Inhibition of Gα<sub>q</sub> and MEK Enhances Therapeutic Efficacy in Uveal Melanoma.Clin Cancer Res2021
33004339TRK xDFG Mutations Trigger a Sensitivity Switch from Type I to II Kinase Inhibitors.Cancer Discov2021
33323400The Genetic Evolution of Treatment-Resistant Cutaneous, Acral, and Uveal Melanomas.Clin Cancer Res2021
34741162The context-specific role of germline pathogenicity in tumorigenesis.Nat Genet2021
34405229A Comprehensive Comparison of Early-Onset and Average-Onset Colorectal Cancers.J Natl Cancer Inst2021
33833465Respiratory complex and tissue lineage drive recurrent mutations in tumour mtDNA.Nat Metab2021
34405229A Comprehensive Comparison of Early-Onset and Average-Onset Colorectal Cancers.J Natl Cancer Inst2021
34741162The context-specific role of germline pathogenicity in tumorigenesis.Nat Genet2021
34250397Utility of Serial cfDNA NGS for Prospective Genomic Analysis of Patients on a Phase I Basket Study.JCO Precis Oncol2021
34250384Prevalence and Characterization of Biallelic and Monoallelic <i>NTHL1</i> and <i>MSH3</i> Variant Carriers From a Pan-Cancer Patient Population.JCO Precis Oncol2021
34103301Recurrent Mutations in Cyclin D3 Confer Clinical Resistance to FLT3 Inhibitors in Acute Myeloid Leukemia.Clin Cancer Res2021
34090768Erratum to 'Germline-focussed analysis of tumour-only sequencing: recommendations from the ESMO Precision Medicine Working Group': [Annals of Oncology 30 (2019) 1221-1231].Ann Oncol2021
34135330Homing in on genomic instability as a therapeutic target in cancer.Nat Commun2021
33229459Combined Inhibition of Gα<sub>q</sub> and MEK Enhances Therapeutic Efficacy in Uveal Melanoma.Clin Cancer Res2021
33199492Targeting Germline- and Tumor-Associated Nucleotide Excision Repair Defects in Cancer.Clin Cancer Res2021
33303690AKT1 E17K Inhibits Cancer Cell Migration by Abrogating β-Catenin Signaling.Mol Cancer Res2021
33323400The Genetic Evolution of Treatment-Resistant Cutaneous, Acral, and Uveal Melanomas.Clin Cancer Res2021
31570517Regorafenib in Combination with First-Line Chemotherapy for Metastatic Esophagogastric Cancer.Oncologist2020
31794323Cancer Susceptibility Mutations in Patients With Urothelial Malignancies.J Clin Oncol2020
32312891Capivasertib, an AKT Kinase Inhibitor, as Monotherapy or in Combination with Fulvestrant in Patients with <i>AKT1</i> <sup>E17K</sup>-Mutant, ER-Positive Metastatic Breast Cancer.Clin Cancer Res2020
32187176Modeling cancer genomic data in yeast reveals selection against ATM function during tumorigenesis.PLoS Genet2020
32066867Loss of glucocorticoid receptor expression mediates in vivo dexamethasone resistance in T-cell acute lymphoblastic leukemia.Leukemia2020
32178965Clinical and molecular correlates of PD-L1 expression in patients with lung adenocarcinomas.Ann Oncol2020
32299819Genomic Landscape of Uterine Sarcomas Defined Through Prospective Clinical Sequencing.Clin Cancer Res2020
31725847Development of Genome-Derived Tumor Type Prediction to Inform Clinical Cancer Care.JAMA Oncol2020
  • 1 - 50 of 308

Recommended Authors

Sebastian Uhrig
National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ)
Career Start Year 2016
Number of shared co-authors 4
Zachary L Skidmore
Washington University in St. Louis School of Medicine
Career Start Year 2015
Number of shared co-authors 6
Matthew H Bailey
Department of Biology at Brigham Young University
Career Start Year 2013
Number of shared co-authors 44
Michelle Chan-Seng-Yue
Princess Margaret Cancer Centre
Career Start Year 2012
Number of shared co-authors 14
Matti Annala
University of British Columbia
Career Start Year 2011
Number of shared co-authors 10
Arshi Arora
Memorial Sloan Kettering Cancer Center
Career Start Year 2011
Number of shared co-authors 26
Gunes Gundem
Memorial Sloan Kettering Cancer Center
Career Start Year 2010
Number of shared co-authors 25
David A Quigley
University of California-San Francisco
Career Start Year 2008
Number of shared co-authors 18
Oscar Krijgsman
The Netherlands Cancer Institute
Career Start Year 2008
Number of shared co-authors 3
Ignaty Leshchiner
Broad Institute of Massachusetts Institute of Technology and Harvard
Career Start Year 2008
Number of shared co-authors 23
David C Wedge
Manchester Cancer Research Centre, University of Manchester
Career Start Year 2006
Number of shared co-authors 19
Jamie K Teer
H. Lee Moffitt Cancer Center and Research Institute
Career Start Year 2005
Number of shared co-authors 5
Christina Curtis
Stanford University School of Medicine
Career Start Year 2004
Number of shared co-authors 12
Jesse S Boehm
Broad Institute of Harvard and MIT
Career Start Year 2004
Number of shared co-authors 34
Michael D McLellan
McDonnell Genome Institute, Washington University in St. Louis
Career Start Year 2003
Number of shared co-authors 53
Obi L Griffith
Washington University
Career Start Year 2003
Number of shared co-authors 31
Peter Van Loo
The Francis Crick Institute
Career Start Year 2003
Number of shared co-authors 20
Sherri Z Millis
Foundation Medicine Inc
Career Start Year 2003
Number of shared co-authors 7
Peter Horak
German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT)
Career Start Year 2003
Number of shared co-authors 7
Trevor J Pugh
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2003
Number of shared co-authors 52
Volker Endris
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2001
Number of shared co-authors 7
Luciano G Martelotto
Monash University
Career Start Year 2000
Number of shared co-authors 17
Nikhil Wagle
Dana-Farber Cancer Institute
Career Start Year 2000
Number of shared co-authors 44
Xuhong Cao
Michigan Center for Translational Pathology.
Career Start Year 1999
Number of shared co-authors 43
Tobias Sj??blom
Uppsala University
Career Start Year 1999
Number of shared co-authors 3
Anthony J Iafrate
Massachusetts General Hospital
Career Start Year 1997
Number of shared co-authors 38
Li Ding
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year 1997
Number of shared co-authors 99
Stefan Fr??hling
German Cancer Research Center (DKFZ), National Center for Tumor Diseases (NCT)
Career Start Year 1996
Number of shared co-authors 11
Ultan McDermott
Wellcome Sanger Institute
Career Start Year 1993
Number of shared co-authors 23
Phillip A Futreal
The University of Texas MD Anderson Cancer Center
Career Start Year 1991
Number of shared co-authors 56

Collaborators

Michael F Berger
Co-authored papers 50
Nikolaus Schultz
Memorial Sloan Kettering Cancer Center
Co-authored papers 40
Marc Ladanyi
Memorial Sloan Kettering Cancer Center
Co-authored papers 34
Chris Sander
Broad Institute of MIT and Harvard
Co-authored papers 23
Chaitanya Bandlamudi
Co-authored papers 19
José Baselga
Co-authored papers 18
Agnes Viale
Memorial Sloan Kettering Cancer Center
Co-authored papers 18
Jianjiong Gao
Memorial Sloan Kettering Cancer Center
Co-authored papers 17
Nicholas D Socci
Co-authored papers 17
Ritika Kundra
Memorial Sloan Kettering Cancer Center
Co-authored papers 13
Charles L Sawyers
Memorial Sloan Kettering Cancer Center
Co-authored papers 10
Victor E Reuter
Memorial Sloan Kettering Cancer Center
Co-authored papers 10
Charles M Rudin
Memorial Sloan Kettering Cancer Center
Co-authored papers 10
Debyani Chakravarty
Memorial Sloan Kettering Cancer Center
Co-authored papers 10
Alexander Drilon
Memorial Sloan Kettering Cancer Center
Co-authored papers 9
Christine A Pratilas
Johns Hopkins University School of Medicine
Co-authored papers 9
Walid K Chatila
Memorial Sloan Kettering Cancer Center
Co-authored papers 9
Wassim Abida
Memorial Sloan Kettering Cancer Center
Co-authored papers 8
Howard I Scher
Memorial Sloan Kettering Cancer Center
Co-authored papers 8
Elisa de Stanchina
Co-authored papers 8
Timothy A Chan
Cleveland Clinic.
Co-authored papers 8
Gregory J Riely
Memorial Sloan Kettering Cancer Center
Co-authored papers 7
Saurabh Asthana
University of California San Francisco
Co-authored papers 7
Cyriac Kandoth
University of California los angeles
Co-authored papers 7
Cristina R Antonescu
Memorial Sloan Kettering Cancer Center
Co-authored papers 6
Cameron Brennan
Co-authored papers 6
Joshua Armenia
Oncology R&D
Co-authored papers 6
Arul M Chinnaiyan
University of Michigan Medical School.
Co-authored papers 6
Liying Zhang
The Fifth Affiliated Hospital, Sun Yat-sen University
Co-authored papers 6
Michael F Walsh
Memorial Sloan Kettering Cancer Center
Co-authored papers 6
Release 1.2